Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Morphic Therapeutic's peak revenue was $70.8M in 2022. The peak quarterly revenue was $60.2M in 2022(q2).
Morphic Therapeutic's revenue increased from $3.4m in 2018 to $521.0K currently. That's a -84.48% change in annual revenue.
| Fiscal year / year | Morphic Therapeutic revenue |
|---|---|
| 2018 | $3.4M |
| 2019 | $17.0M |
| 2020 | $44.9M |
| 2021 | $19.8M |
| 2022 | $70.8M |
| 2023 | $521,000 |
Rate Morphic Therapeutic's financial transparency
Morphic Therapeutic saw the greatest revenue growth in 2019, when revenue increased by 405.57%.
Morphic Therapeutic had the lowest revenue growth in 2021, when revenue changed by -55.96%.
| Year | Morphic Therapeutic growth |
|---|---|
| 2019 | 406%↑ |
| 2020 | 165%↑ |
| 2021 | -56%↓ |
| 2022 | 258%↑ |
| 2023 | -99%↓ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | - | $5.6M | $5.7M | ($334.0K) |
| 2020 | $5.6M | $7.7M | $25.8M | $5.9M |
| 2021 | $3.3M | $3.8M | $3.1M | $9.6M |
| 2022 | $2.4M | $60.2M | $2.1M | $6.1M |
| 2023 | $521,000 | - | - | - |
Do you work at Morphic Therapeutic?
Did Morphic Therapeutic meet its revenue projections?
| CEO | Praveen P. Tipirneni |
| Company Type | Public |
| Employees Number | 76 |
| Date Founded | 2015 |
| Headquarters | Waltham, Massachusetts |
| Number of Locations | 1 |
| Revenue | $521,000 |
| Net Income | -$59,041,000 |
| Tax Rate | -0.0% |
| Total Assets | $368,589,000 |
| Ticker | MORF |
Morphic Therapeutic received early financing of $3.0M on 2016-01-01.
| Series | Round size | Date |
|---|---|---|
| Series B - Morphic Therapeutic | $80M | 09/2018 |
| Series A - Morphic Therapeutic | $51.5M | 06/2016 |
| Seed Round - Morphic Therapeutic | $3M | 01/2016 |
| Investors | Security type |
|---|---|
| Pfizer Venture Investments | Series B - Morphic Therapeutic |
| Novo Holdings | Series B - Morphic Therapeutic |
| Invus | Series B - Morphic Therapeutic |
| Polaris Partners | Series B - Morphic Therapeutic |
| Timothy A. Springer | Series B - Morphic Therapeutic |
| SR One | Series B - Morphic Therapeutic |
| Omega Funds | Series B - Morphic Therapeutic |
| EcoR1 Capital | Series B - Morphic Therapeutic |
| SR One | Series A - Morphic Therapeutic |
| Polaris Partners | Series A - Morphic Therapeutic |
Zippia gives an in-depth look into the details of Morphic Therapeutic, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Morphic Therapeutic. The employee data is based on information from people who have self-reported their past or current employments at Morphic Therapeutic. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Morphic Therapeutic. The data presented on this page does not represent the view of Morphic Therapeutic and its employees or that of Zippia.
Morphic Therapeutic may also be known as or be related to Morphic, Morphic Holding, LLC, Morphic Therapeutic and Morphic Therapeutic, Inc.